CTI 103 (Diclofenac sodium delayed release 75 mg)
Pill imprint CTI 103 has been identified as Diclofenac sodium delayed release 75 mg.
Diclofenac is used in the treatment of back pain; pain; muscle pain; sciatica; frozen shoulder (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. There is positive evidence of human fetal risk during pregnancy. Diclofenac 75 mg is not a controlled substance under the Controlled Substance Act (CSA).
- CTI 103
- 75 mg
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Carlsbad Technology, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- ferrosoferric oxide
methacrylic acid - methyl methacrylate copolymer (1:1)
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
Note: Inactive ingredients may vary.
More about diclofenac
- Diclofenac enteric-coated tablets
- Diclofenac extended-release tablets
- Diclofenac immediate-release tablets
- Diclofenac potassium powder packets
- More (2) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.